Intra-articular remodelling of hamstring tendon grafts after anterior cruciate ligament reconstruction

This phase is defined as the period from the time of anterior cruciate ligament reconstruction until the fourth post-operative week. It is marked by increasing necrosis, mainly in the centre of the graft and hypocellularity [3‐5, 28, 46, 51]. An influx of host cells can be seen into the graft’s periphery between the first and second week [27, 28]. The source of these cells is thought to be the synovial fluid, cells from the stump of the native ACL or bone marrow elements originating from drilling the tunnels. Preservation of the ACL stump and Hoffa fat pad may be beneficial for graft healing in this phase [5, 15, 41]. At the same time, no graft revascularization can be observed [5, 27, 50, 64]. Even though beginning disintegration of collagen fibrils and their orientation can be observed as early as 3 weeks after reconstruction [16], the graft’s overall collagen structure and crimp pattern are maintained [3, 4]. This explains the slow decrease in the mechanical properties of the graft in this early healing phase [40, 46, 50]. During this early healing phase, between 2 and 4 weeks, the lack of sufficient biological graft incorporation is the weak site of the reconstruction with consistent failure by graft pullout [16, 17, 40, 58], therefore requiring and relying on appropriate mechanical graft fixation. A shift towards the intra-articular graft region becoming the weak link is noted during the proliferation healing phase when the maximum remodelling activity seems to interfere with the mechanical strength of the healing graft [16, 40, 61].

The proliferation phase is defined as the period between 4 and 12 weeks after ACL reconstruction.

This phase is characterized by maximum cellular activity and changes of the extra-cellular matrix, which are paralleled by the lowest mechanical properties of the reconstructed ACL graft. Graft necrosis leads to a release of growth factors, which stimulate cell migration and proliferation as well as extracellular matrix synthesis and revascularization [22, 26, 29, 51, 64]. An increased number of specific fibroblasts so-called myofibroblasts appear. They are responsible for the restoration of the in situ tension that is required for the later ligamentization phase [36, 46, 56, 62]. At the end of the proliferation phase, cell density is still increased, but recedes towards the intact ACL’s cellularity [6, 21, 24, 46, 51, 55, 58]. Revascularization of the graft starts from the fourth post-operative week [5, 46, 55, 61], progressing from the periphery of the graft to the entire graft diameter at 12 weeks [42, 55].

Animal studies have shown that the mechanical properties of the graft are at its weakest at 6–8 weeks. Three factors contribute to the decline in the grafts’ mechanical properties: (a) increased revascularization and extra-cellular infiltration, (b) loss of regular collagen orientation and crimp pattern and (c) decrease in collagen fibril density, followed by increased collagen synthesis with a shift from large-diameter collagen fibrils to small-diameter fibrils [6, 9, 16, 20, 21, 27, 46, 51, 52, 54, 58, 60, 61]. Furthermore, increased collagen III synthesis (with lower mechanical strength than type I collagen) may further explain why a full restoration of the mechanical strength of the intact ACL has not been observed in any in vivo model even after 2 years of healing [32, 42, 46, 52].

The reduced mechanical properties of healing grafts in animal models seem to contradict the successful clinical outcomes after ACL reconstruction with immediate aggressive rehabilitation in humans. Significant differences were found in biopsy studies between the remodelling activity of human ACL grafts during the first 3 months and the healing graft in animal models. The complete loss and replacement of all intrinsic graft have not been observed in human biopsy studies [25, 43]. The excessive graft necrosis in animals could not be confirmed in humans, where necrosis or degeneration never involved in more than 30 % of the graft’s biopsies [25, 35, 43]. Neovascularization was not as excessive in humans [25]. Large areas of human healing graft stay unchanged displaying tendinous structure with normal collagen alignment and crimp pattern [25]. Loss of collagen organization was only detected in areas of neovascularization in human biopsies, which corresponds to the findings in animal studies [24, 46]. However, human biopsy studies confirm the remodelling cascade of (limited) graft necrosis, recellularization, revascularization and changes in collagen crimp and composition during the early healing and proliferation phases, suggesting that also the human ACL graft might have its lowest mechanical strength around 6–8 weeks post-operatively [43, 65]. Loading of the graft must be high enough to stimulate graft cells to produce cellular and extra-cellular components for preservation of graft stability, but without compromising graft integrity, which might result into an early stretch-out of the ACL reconstruction [46].

The ligamentization phase involves the continuous remodelling of the healing graft towards the morphology and mechanical strength of the intact ACL from 12 weeks onwards. A clear endpoint is not known for certain changes still occurring even years after reconstruction. In animal models, cellularity slowly returns to values of the intact ACL between 3 and 6 months post-operatively [42, 46, 55, 61]. Vascularity throughout the graft decreases and returns to values of the intact ACL between 6 and 12 months, when vessels become evenly distributed throughout the entire graft [5, 46, 55, 61]. Collagen fibres regain their organization, which microscopically resembles the appearance of the intact ACL around 6 and 12 months after reconstruction [46, 62]. However, the initial loss in collagen crimp and strict parallel alignment of the proliferation phase is only partially restored [46, 62]. The heterogeneous composition of collagen fibres of varying diameter of the intact ACL is never restored [1, 21, 31, 58]. It has been shown that the mechanical properties of the ACL-reconstructed knee joint improve substantially during the phase of ligamentization and reach their maximum properties at around 1 year. However, not a single animal study has demonstrated that the structural properties (e.g. failure load, stiffness) of the healing graft could surpass 50–60 % of the intact ACL [6, 9, 16, 21, 37, 38, 40, 46, 60, 61]. While human biopsy studies showed substantial differences from animal models during the proliferation phase, the ligamentization phase is rather similar in both models in terms of biological progression. However, the timeline of these biological changes is different: studies in humans have shown a prolonged remodelling process compared to animal models [10, 12, 24, 30, 33, 43, 44, 46, 53, 65, 66].

MRI studies have examined the revascularization of human hamstring autografts after ACL reconstruction [13, 15, 18, 57]. In a gadolinium-enhanced MRI study, Howell et al. [18] did not demonstrate any discernible blood supply in an unimpinged 4-strand hamstring ACL graft during the 2 years of implantation. The graft retained the same hypovascular appearance as the normal posterior cruciate ligament. In contrast, the periligamentous soft tissues were richly vascularized and covered the graft by 1 month. They postulated that the viability of an unimpinged, human hamstring ACL graft may depend more on synovial diffusion than on revascularization. This is in contrast to findings in animal studies, where gadolinium-enhanced MRI showed significant upregulated neovascularization during the first 3 post-operative months [61]. This underlines the differences in remodelling between humans and animal models. Although human biopsy studies have shown that neovascularization of the hamstring graft occurs, the extent of vascularity in humans might be below the threshold detectable with gadolinium-enhanced MRI [46]. Gohil et al. [15] investigated the effect of minimal debridement of the stump of the ruptured ACL on revascularization of 4-strand human hamstring ACL autografts. They concluded that minimal debridement led to earlier revascularization within the midsubstance of the ACL graft at 2 months, but found no evidence that the minimal debridement accelerated the recovery of graft strength. Other authors examined the effect of autologous platelet concentrate on remodelling of 4-strand human hamstring ACL autografts with a standardized accelerated rehabilitation protocol. Vogrin et al. [57] used contrast-enhanced MRI and found that revascularization of the graft only started at 4–6 weeks after ACL reconstruction. Autologous platelet concentrate did not influence intra-articular remodelling of hamstring grafts [13, 57]. The revascularization of the human hamstring graft at 4–6 weeks correlates with the proliferation phase of graft healing.

Human biopsy studies have examined the remodelling process of the hamstring tendon autograft at various time intervals after clinically successful ACL reconstruction [10, 12, 13, 24, 30, 33, 44, 47, 66]. The human hamstring autograft remains viable after reconstruction and shows typical stages of remodelling: early phase graft healing, a proliferation phase and a ligamentization phase [10, 12, 24, 44]. Graft integrity is much less compromised during the early healing and proliferation phase in human ACL grafts, which might allow for the assumption that the mechanical properties are also substantially higher than in animal models during the first 3 post-operative months [10, 25, 46].

Focus of human hamstring biopsy studies has been the proliferation and ligamentization phases of graft healing, as most biopsies were taken at second-look arthroscopies from 4 months onwards after ACL reconstruction. Janssen et al. [24] examined 67 patients who underwent retrieval of midsubstance biopsies after clinically successful 4-strand hamstring autograft ACL reconstruction with a standardized accelerated rehabilitation programme. Cellular density and vascular density were increased up to 24 months after ACL reconstruction. Especially the strong increase in myofibroblast density, from 13 up to 24 months, indicated an active remodelling process from 1 to 2 years (Fig. 1). Furthermore, vessel density increased over 24 months, whereas cell and myofibroblast density decreased but stayed higher than native hamstring and ACL controls. Collagen orientation did not return to normal in the study period (up to 117 months after ACL reconstruction).

Human biopsy studies that analysed changes of the extracellular matrix observed changes that are in line with the findings of animal models. Marumo et al. [33] found that the collagen cross-links of hamstring tendon autografts had changed from time zero, when they were significantly different from the intact ACL, to 1 year post-operatively, when both grafts had acquired cross-link ratios that were identical to the intact ACL, confirming the ligamentization process found in animal models. Interestingly, biopsy specimens taken at 6 months still showed significantly different cross-link ratios of the healing grafts compared to the intact ACL, which is different from the earlier cross-link restoration found in animal models [30, 46]. This also confirms the different timeline of the remodelling of human ACL grafts. Zaffagnini et al. [66] confirmed the observations in animal models [22, 31, 61] that human hamstring ACL grafts showed a replacement of large- by small-diameter fibrils, which did not change even after more than 2 years. Sanchez et al. [44] showed that use of platelet-rich plasma preparation rich in growth factors (PRGF) in hamstring ACL autografts resulted in temporal histological changes during the 6- to 24-month post-operative period in comparison with non-PRGF-treated grafts. Biopsies were taken from the periphery of the hamstring autograft, and the authors question whether these ACL substitutes entirely replicate the full mechanical properties of the intact ACL. A better understanding of the graft biology in human ACL reconstruction will depend on the possibility to obtain core biopsy samples of the grafts [10].

In summary, human hamstring ACL autografts undergo a process of adaptation rather than full restoration of the intact ACL’s biological properties, which takes at least 1 year after reconstruction.